DWA
CELG

Douglass Winthrop Advisors’s Celgene Corp CELG Stock Holding History

Douglass Winthrop Advisors’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-3,798
Closed -$377K – 271
2019
Q3 		$377K Hold
3,798
– – 0.01% 206
2019
Q2 		$351K Sell
3,798
-500
-12% -$47.5K 0.01% 209
2019
Q1 		$405K Sell
4,298
-2,900
-40% -$254K 0.02% 180
2018
Q4 		$461K Sell
7,198
-340
-5% -$25.1K 0.02% 166
2018
Q3 		$675K Sell
7,538
-700
-8% -$61.9K 0.03% 147
2018
Q2 		$654K Sell
8,238
-7,800
-49% -$648K 0.03% 178
2018
Q1 		$1.43M Sell
16,038
-5,410
-25% -$519K 0.07% 128
2017
Q4 		$2.24M Buy
21,448
+1,854
+9% +$209K 0.12% 86
2017
Q3 		$2.86M Sell
19,594
-855
-4% -$116K 0.17% 72
2017
Q2 		$2.66M Buy
20,449
+5,125
+33% +$628K 0.16% 72
2017
Q1 		$1.91M Buy
15,324
+1,000
+7% +$120K 0.12% 83
2016
Q4 		$1.66M Buy
14,324
+400
+3% +$44.5K 0.11% 89
2016
Q3 		$1.46M Buy
13,924
+3,436
+33% +$372K 0.1% 92
2016
Q2 		$1.03M Sell
10,488
-1,000
-9% -$103K 0.07% 114
2016
Q1 		$1.15M Buy
11,488
+728
+7% +$75K 0.08% 104
2015
Q4 		$1.29M Buy
10,760
+700
+7% +$81K 0.1% 107
2015
Q3 		$1.09M Buy
10,060
+2,350
+30% +$292K 0.09% 115
2015
Q2 		$889K Hold
7,710
– – 0.07% 132
2015
Q1 		$889K Sell
7,710
-50
-0.6% -$5.97K 0.07% 132
2014
Q4 		$868K Buy
7,760
+328
+4% +$34.6K 0.08% 105
2014
Q3 		$704K Buy
7,432
+342
+5% +$30.9K 0.06% 109
2014
Q2 		$609K Sell
7,090
-332
-4% -$25.2K 0.06% 110
2014
Q1 		$518K Buy
7,422
+1,582
+27% +$125K 0.05% 112
2013
Q4 		$493K Buy
5,840
+800
+16% +$63.3K 0.05% 114
2013
Q3 		$388K Hold
5,040
– – 0.05% 122
2013
Q2 		$295K Buy
+5,040
New +$303K 0.04% 144

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Douglass Winthrop Advisors's CELG Position: Q4 2019 in Review

Douglass Winthrop Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 3,798 shares — an estimated $377K sold.

Douglass Winthrop Advisors first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $2.86M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Douglass Winthrop Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Douglass Winthrop Advisors sold 3,798 Celgene Corp shares in Q4 2019, an estimated $377K.
  • Douglass Winthrop Advisors first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Douglass Winthrop Advisors's Celgene Corp position peaked at $2.86M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Douglass Winthrop Advisors's 13F filing for Q4 2019, filed 10 Jan 2020.